Correction: Sequential HER2 blockade as effective therapy in chemorefractory, HER2 gene-amplified, RAS wild-type, metastatic colorectal cancer: learning from a clinical case

• Matteo Fassan,
• Chiara Cremolini,
• Matteo Benelli,
• Elisa Fontana,
• Filippo Pagani,
• Daniele Rossini,
• Giovanni Fucà,
• Adele Busico,
• Elena Conca,
• Samantha Di Donato,
• Fotios Loupakis,
• Marta Schirripa,
• Sara Lonardi,
• Beatrice Borelli,
• Elena Ongaro,
• Katherine Eason,
• Mariaelena Casagrande,
• Anguraj Sadanandam,
• Filippo de Braud,
• Alfredo Falcone

Affiliations

Matteo Fassan

Department of Medicine (DIMED), University of Padua, Padova, Italy

Chiara Cremolini

Department of Translational Medicine, Division of Medical Oncology, University of Pisa, Pisa, Italy

Matteo Benelli

3 Bioinformatics Unit, Oncology Department, Hospital of Prato, Prato, Italy

Elisa Fontana

Molecular Pathology, The Institute of Cancer Research, Sutton, UK

Filippo Pagani

6 Medical Oncology Department, Fondazione IRCCS Istituto Nazionale dei Tumori, Milano, Italy

Daniele Rossini

1 Unit of Medical Oncology 2, Azienda Ospedaliero Universitaria Pisana, Pisa, Italy

Giovanni Fucà

6 Medical Oncology Department, Fondazione IRCCS Istituto Nazionale dei Tumori, Milano, Italy

Adele Busico

7 Department of Diagnostic Pathology and Laboratory Medicine, Fondazione IRCCS Istituto Nazionale dei Tumori, Milan, Italy

Elena Conca

7 Department of Diagnostic Pathology and Laboratory Medicine, Fondazione IRCCS Istituto Nazionale dei Tumori, Milan, Italy

Samantha Di Donato

8 Medical Oncology Unit, Oncology Department, Hospital of Prato, Prato, Italy

Fotios Loupakis

Clinical and Experimental Oncology Department, Medical Oncology Unit 1, Veneto Institute of Oncology IOV-IRCCS, Padua, Italy

Marta Schirripa

9 Unit of Medical Oncology 1, Department of Clinical and Experimental Oncology, IRCCS Istituto Oncologico Veneto, Padova, Italy

Sara Lonardi

9 Unit of Medical Oncology 1, Department of Clinical and Experimental Oncology, IRCCS Istituto Oncologico Veneto, Padova, Italy

Beatrice Borelli

1 Unit of Medical Oncology 2, Azienda Ospedaliero Universitaria Pisana, Pisa, Italy

Elena Ongaro

1 Unit of Medical Oncology 2, Azienda Ospedaliero Universitaria Pisana, Pisa, Italy

Katherine Eason

4 Division of Molecular Pathology, The Institute of Cancer Research, London, UK

Mariaelena Casagrande

10 Department of Oncology, Azienda Sanitaria Universitaria Integrata di Udine, Udine, Italy

Anguraj Sadanandam

4 Division of Molecular Pathology, The Institute of Cancer Research, London, UK

Filippo de Braud

6 Medical Oncology Department, Fondazione IRCCS Istituto Nazionale dei Tumori, Milano, Italy

Alfredo Falcone

Department of Translational Medicine, Division of Medical Oncology, University of Pisa, Pisa, Italy